John A. Gillespie, MD, MBA
John A. Gillespie, MD, MBA
Pfizer Inc.
EPBU
235 E42nd St
New York,
NY
USA
10017
Papers:
3.32
Time-Course of Treatment-Emergent Adverse Events Following Administration of an Extended-Release Methylphenidate Oral Suspension